Friday, August 29, 2008

J&J patent related to Razadyne invalidated in D. Del.

A press release by Barr suggests that D. Delaware has invalidated a patent by Johnson & Johnson related to Razadyne, a drug used to treat dementia related to Alzheimer's disease.

The basis was lack of enablement.


Post a Comment

<< Home